Correlation Between Spectral Med and BioAffinity Technologies,

Can any of the company-specific risk be diversified away by investing in both Spectral Med and BioAffinity Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spectral Med and BioAffinity Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spectral Med and bioAffinity Technologies,, you can compare the effects of market volatilities on Spectral Med and BioAffinity Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spectral Med with a short position of BioAffinity Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spectral Med and BioAffinity Technologies,.

Diversification Opportunities for Spectral Med and BioAffinity Technologies,

-0.32

Correlation Coefficient

Spectral Med  BioAffinity Technologies,

Very good diversification

The 3 months correlation between Spectral and BioAffinity is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Spectral Med and bioAffinity Technologies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on bioAffinity Technologies, and Spectral Med is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spectral Med are associated (or correlated) with BioAffinity Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of bioAffinity Technologies, has no effect on the direction of Spectral Med i.e., Spectral Med and BioAffinity Technologies, go up and down completely randomly.

Pair Corralation between Spectral Med and BioAffinity Technologies,

Assuming the 90 days horizon Spectral Med is expected to generate 3.38 times less return on investment than BioAffinity Technologies,. But when comparing it to its historical volatility, Spectral Med is 5.17 times less risky than BioAffinity Technologies,. It trades about 0.04 of its potential returns per unit of risk. bioAffinity Technologies, is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  38.00  in bioAffinity Technologies, on May 5, 2025 and sell it today you would lose (9.00) from holding bioAffinity Technologies, or give up 23.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Spectral Med  vs.  bioAffinity Technologies,

Spectral Med

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Spectral Med are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Spectral Med may actually be approaching a critical reversion point that can send shares even higher in September 2025.

bioAffinity Technologies,

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in bioAffinity Technologies, are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BioAffinity Technologies, reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Spectral Med and BioAffinity Technologies,

The main advantage of trading using opposite Spectral Med and BioAffinity Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spectral Med position performs unexpectedly, BioAffinity Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies, will offset losses from the drop in BioAffinity Technologies,'s long position.

The idea behind Spectral Med and bioAffinity Technologies, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.